D. Draganov

发表

Lack of Neuropathological Changes in Rats Administered Tedizolid Phosphate for Nine Months

M. Butt, A. Radovsky, M. Schlosser, 2014, Antimicrobial Agents and Chemotherapy.

Apolipoprotein A-I Promotes the Formation of Phosphatidylcholine Core Aldehydes That Are Hydrolyzed by Paraoxonase (PON-1) during High Density Lipoprotein Oxidation with a Peroxynitrite Donor*

A. Emili, A. Kuksis, A. Ravandi, 2001, The Journal of Biological Chemistry.

PONs’ Natural Substrates – The Key for their Physiological Roles

D. Draganov, J. Teiber, 2008 .

The Role of hsp90 in Heme-dependent Activation of Apo-neuronal Nitric-oxide Synthase*

W. Pratt, P. Murphy, Y. Morishima, 2004, Journal of Biological Chemistry.

Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite.

P. Connelly, G. Maguire, D. Draganov, 2005, Free radical biology & medicine.

Paraoxonase-1 reduces monocyte chemotaxis and adhesion to endothelial cells due to oxidation of palmitoyl, linoleoyl glycerophosphorylcholine.

A. Kuksis, P. Connelly, Z. Ahmed, 2003, Cardiovascular research.

Development of an immunoblot assay with infrared fluorescence to quantify paraoxonase 1 in serum and plasma Published, JLR Papers in Press, September 28, 2007.

P. Connelly, G. Maguire, D. Draganov, 2008, Journal of Lipid Research.

Mouse Macrophage Paraoxonase 2 Activity Is Increased Whereas Cellular Paraoxonase 3 Activity Is Decreased Under Oxidative Stress

C. Watson, B. La Du, C. Bisgaier, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Paraoxonase-1 and clopidogrel efficacy

Dan S. Tawfik, Antonio F. Hernández, D. Shih, 2011, Nature Medicine.

Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3.

B. La Du, D. Draganov, J. Teiber, 2003, Biochemical pharmacology.

Pharmacogenetics of paraoxonases: a brief review

B. La Du, D. Draganov, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Rabbits possess a serum paraoxonase polymorphism similar to the human Q192R.

C. Watson, B. La Du, C. Bisgaier, 2001, Pharmacogenetics.

Separation and quantitative recovery of mouse serum arylesterase and carboxylesterase activity Published, JLR Papers in Press, January 1, 2004. DOI 10.1194/jlr.M300464-JLR200

P. Connelly, G. Maguire, D. Draganov, 2004, Journal of Lipid Research.

Multiple substrates for paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite.

A. Emili, A. Kuksis, A. Ravandi, 2002, Biochemical and biophysical research communications.

Estrogen esters as substrates for human paraoxonases.

B. La Du, D. Draganov, J. Teiber, 2007, Archives of biochemistry and biophysics.

Subcutaneous Site-of-Absorption Study with the Monoclonal Antibody Tocilizumab in Minipigs: Administration Behind Ear Translates Best to Humans

Uwe Wessels, H. Grimm, W. Richter, 2020, The AAPS Journal.

Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiess⃞s⃞ The online version of this article (available at http://www.jlr.org) contains additional text, figures, and references. Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M

R. Sunahara, B. La Du, Dragomir I Draganov, 2005, Journal of Lipid Research.

Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters.

C Watson, P. Stetson, R. Counsell, 2000, Drug metabolism and disposition: the biological fate of chemicals.

LTBP2 and CYP1B1 mutations and associated ocular phenotypes in the Roma/Gypsy founder population

R. Kaneva, M. Juan, P. Majumder, 2011, European Journal of Human Genetics.

Preliminary pharmacokinetics of tramadol hydrochloride after administration via different routes in male and female B6 mice.

Guido Steiner, M. Arras, A. Bergadano, 2017, Veterinary anaesthesia and analgesia.

Lactonases with organophosphatase activity: structural and evolutionary perspectives.

D. Draganov, 2010, Chemico-biological interactions.

Dominant Role of Paraoxonases in Inactivation of the Pseudomonas aeruginosa Quorum-Sensing Signal N-(3-Oxododecanoyl)-l-Homoserine Lactone

R. Haley, Junhui Xiao, G. Kramer, 2008, Infection and Immunity.

Rabbit Serum Paraoxonase 3 (PON3) Is a High Density Lipoprotein-associated Lactonase and Protects Low Density Lipoprotein against Oxidation*

P. Stetson, C. Watson, B. La Du, 2000, The Journal of Biological Chemistry.

PON1 and oxidative stress in human sepsis and an animal model of sepsis.

T. Standiford, D. Remick, J. Nemzek, 2010, Advances in experimental medicine and biology.

Human PON3, effects beyond the HDL: clues from human PON3 transgenic mice.

D. Draganov, 2007, Circulation research.

Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities.

M. Aviram, J. Vaya, A. Hoffman, 2000, Circulation.

Extensive metabolism and route-dependent pharmacokinetics of bisphenol A (BPA) in neonatal mice following oral or subcutaneous administration.

R. Budinsky, S. Dimond, S. Hentges, 2015, Toxicology.

Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein

M. Merchant, Björn Wagner, H. Fischer, 2020, Neuro-oncology.

High-performance liquid chromatography analysis of N-acyl homoserine lactone hydrolysis by paraoxonases.

D. Draganov, J. Teiber, 2011, Methods in molecular biology.

Results of screening and treatment of retinopathy of prematurity over a 10-year period in one neonatal unit of Bulgaria

K. Dokova, G. Adams, S. Nikolova, 2006 .